MedPath

Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode

Not Applicable
Terminated
Conditions
Hearing Disorders
Deafness
Ear Diseases
Hearing Loss
Otorhinolaryngologic Diseases
Interventions
Device: HiRes™ 90K Advantage implant with HiFocus™ Mid-Scala electrode
Registration Number
NCT01959152
Lead Sponsor
Advanced Bionics
Brief Summary

The purpose of this study is to determine the feasibility of preserving low-frequency acoustic hearing in adults with a moderate degree of hearing loss in the low frequencies and severe-to-profound hearing loss in the mid-to-high frequencies who are implanted with the HiRes™ 90K Advantage implant with HiFocus™ Mid-Scala electrode.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • No previous cochlear implant experience
  • 18 years of age or older
  • Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone average ≤ 65 dB HL for 125, 250, 500, and 1000 Hz) and a severe-to-profound sensorineural hearing loss in the high frequencies (pure tone average ≥ 70 dB HL for 2,000, 4,000, and 8,000 Hz) in the ear to be implanted
  • Aided monosyllabic word score of 10-50% in the ear to be implanted
  • Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone average ≤ 65 dB HL for 125, 250, 500, and 1000 Hz) and a severe-to-profound sensorineural hearing loss in the high frequencies (pure tone average ≥ 70 dB HL for 2,000, 4,000, and 8,000 Hz) in the contralateral (non-implanted) ear
  • English language proficiency
  • Willingness to participate in all scheduled procedures outlined in the protocol
Exclusion Criteria
  • Previous inner ear surgery
  • Cochlear malformation or obstruction that would preclude full insertion of electrode array
  • Presence of additional disabilities that would prevent or interfere with participation in the required study procedures
  • Medical or psychological conditions that contraindicate surgery or impact the ability to manage an implanted device or the study-related procedures
  • Evidence of central auditory lesion or compromised auditory nerve

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
HiRes90K™ Advantage Cochlear ImplantHiRes™ 90K Advantage implant with HiFocus™ Mid-Scala electrodeHiRes90K™ Advantage implant with HiFocus™ Mid-Scala electrode will be implanted in adults with a moderate level of hearing loss in the low frequencies and severe-to-profound hearing loss in the mid-to-high frequencies.
Primary Outcome Measures
NameTimeMethod
Low-frequency unaided acoustic hearing thresholds pre and post implantation with the HiFocus™ Mid-Scala electrode arrayOne month

Unaided low-frequency acoustic hearing thresholds (under earphones) in the implanted ear one month after device activation will be compared to baseline (pre-implant) thresholds in the same ear for audiometric frequencies 125-1000Hz. Threshold changes from baseline will be calculated as:

* Complete preservation of hearing: threshold shift ≤ 15 dB

* Partial preservation of hearing: threshold shift ≥ 16 dB with measurable thresholds

* No preservation of hearing: no measurable thresholds at ≤ 80 dB HL

Secondary Outcome Measures
NameTimeMethod
Word recognition in quiet pre and post implantation with the HiFocus™ Mid-Scala electrode arrayOne month

Word recognition scores in quiet in the implanted ear one month after device activation compared to pre-implant score with a hearing aid

Trial Locations

Locations (3)

Dalhousie University, Department of Surgery, Division of Otolaryngology

🇨🇦

Halifax, Nova Scotia, Canada

The Ottawa Hospital, Parkdale Clinic, Audiology Department

🇨🇦

Ottawa, Ontario, Canada

Sunnybrook Health Sciences Centre, Department of Otolaryngology - Head and Neck Surgery

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath